Patient Resources
Get Healthy!
Semaglutide Helps Prevent Kidney Damage in People with Obesity
- October 29, 2024
- HealthDayTV HealthDay Reporter
A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.
